These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 6684456

  • 1. Study on the protection of CDP-choline against nicotine intoxication.
    Grau T, Romero A, Sacristán A, Ortiz JA.
    Arzneimittelforschung; 1983; 33(7A):1025-6. PubMed ID: 6684456
    [Abstract] [Full Text] [Related]

  • 2. Dissimilar effects in acute toxicity studies of CDP-choline and choline.
    Agut J, Font E, Sacristán A, Ortiz JA.
    Arzneimittelforschung; 1983; 33(7A):1016-8. PubMed ID: 6684453
    [Abstract] [Full Text] [Related]

  • 3. Pharmacological study of oral CDP-choline. Interaction with oxotremorine on the parasympathetic system.
    Tornos ME, Sacristán A, Ortiz JA.
    Arzneimittelforschung; 1983; 33(7A):1026-9. PubMed ID: 6684457
    [Abstract] [Full Text] [Related]

  • 4. CDP-choline: acute toxicity study.
    Grau T, Romero A, Sacristán A, Ortiz JA.
    Arzneimittelforschung; 1983; 33(7A):1033-4. PubMed ID: 6684459
    [Abstract] [Full Text] [Related]

  • 5. Study of the effects of oral administration of CDP-choline on EEG changes and lethality induced by epidural compression in the anaesthetised cat.
    Algate DR, Beard DJ, Sacristán A, Ortiz JA, Davies JE.
    Arzneimittelforschung; 1983; 33(7A):1013-6. PubMed ID: 6684452
    [Abstract] [Full Text] [Related]

  • 6. CDP-choline: 6-month study on toxicity in dogs.
    Romero A, Grau T, Sacristán A, Ortiz JA.
    Arzneimittelforschung; 1983; 33(7A):1038-42. PubMed ID: 6684461
    [Abstract] [Full Text] [Related]

  • 7. Study of subacute toxicity of CDP-choline after 30 days of oral administration to rats.
    Romero A, Grau T, Sacristán A, Ortiz JA.
    Arzneimittelforschung; 1983; 33(7A):1035-8. PubMed ID: 6684460
    [Abstract] [Full Text] [Related]

  • 8. Effect of oral CDP-choline on acrylamide-induced lesion.
    Agut J, Font E, Sacristán A, Ortiz JA.
    Arzneimittelforschung; 1983; 33(7A):1029-33. PubMed ID: 6684458
    [Abstract] [Full Text] [Related]

  • 9. Pharmacological study of CDP-choline. Protection against toxicity in a model of experimental hypoxia.
    Tornos ME, Sacristán A, Ortiz JA.
    Arzneimittelforschung; 1983; 33(7A):1022-4. PubMed ID: 6684455
    [Abstract] [Full Text] [Related]

  • 10. High-resolution autoradiography in mouse brain and cerebellum 10 days after radiolabelled CDP-choline administration.
    Romero A, Serratosa J, Sacristán A, Ortiz JA.
    Arzneimittelforschung; 1983; 33(7A):1058-60. PubMed ID: 6684467
    [Abstract] [Full Text] [Related]

  • 11. Effect of oral CDP-choline on experimental withdrawal syndrome.
    Tornos ME, Sacristán A, Ortiz JA.
    Arzneimittelforschung; 1983; 33(7A):1018-21. PubMed ID: 6684454
    [Abstract] [Full Text] [Related]

  • 12. Cytidine diphosphate choline (citicoline, Somazina).
    Arzneimittelforschung; 1983; 33(7A):1011-80. PubMed ID: 6684451
    [No Abstract] [Full Text] [Related]

  • 13. Low-resolution autoradiography in rat brain after administering labelled CDP-choline.
    Romero A, Serratosa J, Sacristán A, Ortiz JA.
    Arzneimittelforschung; 1983; 33(7A):1054-6. PubMed ID: 6684465
    [Abstract] [Full Text] [Related]

  • 14. CDP-choline: repeated oral dose tolerance studies in adult healthy volunteers.
    Dinsdale JR, Griffiths GK, Castelló J, Maddock J, Ortiz JA, Aylward M.
    Arzneimittelforschung; 1983; 33(7A):1061-5. PubMed ID: 6684468
    [Abstract] [Full Text] [Related]

  • 15. High-resolution autoradiography in mouse brain 24 h after radiolabelled CDP-choline administration.
    Romero A, Serratosa J, Sacristán A, Ortiz JA.
    Arzneimittelforschung; 1983; 33(7A):1056-8. PubMed ID: 6684466
    [Abstract] [Full Text] [Related]

  • 16. Treatment of chronic dyskinesia with CDP-choline.
    Arranz J, Ganoza C.
    Arzneimittelforschung; 1983; 33(7A):1071-3. PubMed ID: 6684469
    [Abstract] [Full Text] [Related]

  • 17. Oxotremorine-induced cholinergic syndrome: modifications by levodopa and/or oral cytidine diphosphocholine.
    Saligaut C, Daoust M, Chadelaud M, Moore N, Chretien P, Boismare F.
    Methods Find Exp Clin Pharmacol; 1985 Jan; 7(1):5-8. PubMed ID: 3990445
    [Abstract] [Full Text] [Related]

  • 18. Action of CDP-choline by intraduodenal route on rat cardiorespiratory system.
    Brasó MA, Sacristán A, Ortiz JA.
    Arzneimittelforschung; 1983 Jan; 33(7A):1043-5. PubMed ID: 6684462
    [Abstract] [Full Text] [Related]

  • 19. Partial protection by CDP-choline against kainic acid-induced lesion in the rat caudate nucleus.
    Porceddu ML, Concas A.
    Farmaco Sci; 1985 Aug; 40(8):617-22. PubMed ID: 4043378
    [Abstract] [Full Text] [Related]

  • 20. Bioavailability of methyl-14C CDP-choline by oral route.
    Agut J, Font E, Sacristán A, Ortiz JA.
    Arzneimittelforschung; 1983 Aug; 33(7A):1045-7. PubMed ID: 6684463
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.